(Q33407019)

26 July 2017

title

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children (English)

1 reference

pneumococcal conjugate vaccine

26 July 2017

main subject

1 reference

Allison Naleway

11

0 references

Steven J Jacobsen

object named as

Steven J Jacobsen

13

0 references

Eric S Weintraub

6

object named as

Eric Weintraub

1 reference

26 July 2017

12

James Nordin

1 reference

26 July 2017

8

Roger Baxter

1 reference

26 July 2017

9

Jason M Glanz

1 reference

26 July 2017

Hung Fu Tseng

1

1 reference

26 July 2017

Lina S Sy

2

1 reference

26 July 2017

In-Lu Amy Liu

3

1 reference

26 July 2017

Lei Qian

4

1 reference

26 July 2017

S Michael Marcy

5

1 reference

26 July 2017

Katherine Yih

7

1 reference

26 July 2017

James Donahue

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

8 April 2013

1 reference

26 July 2017

1 reference

26 July 2017

volume

31

1 reference

26 July 2017

issue

22

1 reference

26 July 2017

page(s)

2578-2583

1 reference

Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

The future of pneumococcal disease prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

The Vaccine Safety Datalink: a model for monitoring immunization safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association betw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

A Multiple Testing Procedure for Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.040

10.1016/J.VACCINE.2013.03.040

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference